BVXV - Biondvax Pharmaceuticals Ltd - ADR
Close
1.305
-0.045 -3.448%
Share volume: 3,499
Last Updated: Fri 01 Sep 2023 10:00:00 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$1.35
-0.05
-3.33%
Summary score
58%
Profitability
50%
Dept financing
50%
Liquidity
45%
Performance
70%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.09%
Return on assets
-16.22%
Return on sales
0%
Return on invested capital
600.92%
Total debt ratio
70.13%
Debt ratio change over timeo
3.5%
Current Ratio
16.21%
Quick Ratio
0%
Cash Position Ratio
12.69%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
57.7%
Return on assets
-26.81%
Return on sales
0%
Return on invested capital
-146.36%
Total debt ratio
175.95%
Debt ratio change over timeo
38.01%
Current Ratio
3.69%
Quick Ratio
0%
Cash Position Ratio
3.61%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-8.98%
Return on assets
-148.26%
Return on sales
0%
Return on invested capital
-87.24%
Total debt ratio
349.63%
Debt ratio change over time
3.5%
Current Ratio
-5.53%
Quick Ratio
0%
Cash Position Ratio
-1.26%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BVXV | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -6.09% | -4.84% | -11.82% | 0% |
| Return on assets | -16.22% | -4.61% | -10.3% | 0% |
| Return on sales | 0% | -37.52% | 0% | 0% |
| Return on invested capital | 600.92% | 283.27% | -26.85% | 0% |
| Profitability | 50% | 12% | 0% | 50% |
| Total debt ratio | 70.13% | 18.35% | 14.35% | 0% |
| Debt ratio change over time | 3.5% | -1.66% | -1.57% | 0% |
| Dept financing | 50% | 7% | 5% | 0% |
| Current Ratio | 3.69% | 4.23% | 5.16% | 0% |
| Quick Ratio | 0% | 3.89% | 0% | 0% |
| Cash Position Ratio | 3.61% | 0.78% | 1.35% | 0% |
| Liquididy | 50% | 33% | 14% | 0% |
| Short-term ratios | BVXV | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | 57.7% | -4.89% | -13.34% | 0% |
| Return on assets | -26.81% | -3.47% | -11.31% | 0% |
| Return on sales | 0% | -30.25% | 0% | 0% |
| Return on invested capital | -146.36% | -11.86% | -22.44% | 0% |
| Profitability | 50% | 0% | 0% | 50% |
| Total debt ratio | 175.95% | 16.14% | 15.99% | 0% |
| Debt ratio change over time | 38.01% | -2.92% | -1.73% | 0% |
| Dept financing | 50% | 2% | 2% | 0% |
| Current Ratio | 3.69% | 4.23% | 5.16% | 0% |
| Quick Ratio | 0% | 3.89% | 0% | 0% |
| Cash Position Ratio | 3.61% | 0.78% | 1.35% | 0% |
| Liquididy | 43% | 51% | 34% | 0% |